QR-koodi

Streptomyces sp. VITGV156 secondary metabolite binds pathogenic protein PBP2a and Beta-lactamase

IntroductionThe genus Streptomyces is renowned for its prolific production of bioactive compounds, including antibiotics and secondary metabolites with pharmaceutical applications. This study focuses on Streptomyces sp. VITGV156, an isolate with promising antimicrobial properties, aiming to characte...

Täydet tiedot

Tallennettuna:
Päätekijät: Veilumuthu Pattapulavar, Sathiyabama Ramanujam, Manisha Shah, Muthu Kumar Thirunavukkarasu, Sivakumar Arumugam, Ramanathan Karuppasamy, Antony V. Samrot, K. Deepasree, Subhashree Venugopal, John Godwin Christopher
Aineistotyyppi: Artigo
Kieli:Inglês
Julkaistu: Frontiers Media S.A. 2025-03-01
Sarja:Frontiers in Bioinformatics
Aiheet:
Streptomyces
secondary metabolites
antiSMASH
terpenoids
molecular docking
Linkit:https://www.frontiersin.org/articles/10.3389/fbinf.2025.1544800/full
Tagit: Lisää tagi
Ei tageja, Lisää ensimmäinen tagi!

Samankaltaisia teoksia